12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers
Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.
5 Analysts Have This to Say About Scholar Rock Holding
Scholar Rock Holding (NASDAQ:SRRK) has observed the following analyst ratings within the last quarter:
Truist Securities Initiates Coverage On Scholar Rock Holding with Buy Rating, Announces Price Target of $20
Truist Securities analyst Srikripa Devarakonda initiates coverage on Scholar Rock Holding (NASDAQ:SRRK) with a Buy rating and announces Price Target of $20.
Tesla, Twitter And 76 Biggest Movers From Friday
Gainers
Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recommended shareholders to approve a proposed plan sale.
The Daily Biotech Pulse: Merck’s Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
Here's a roundup of top developments in the biotech space over the last 24 hours:
Coinbase, Moderna And 56 Biggest Movers From Yesterday
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition.
Why Is DoorDash Down By 8%? 38 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 69.5% to $2.1199 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition.
Scholar Rock To Present Phase 3 SAPPHIRE Trial Design At The 17th International Congress On Neuromuscular Diseases
Scholar Rock (NASDAQ:SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced an e-poster
InflaRx Climbs More Than 40%, Here’s 58 Biggest Movers From Yesterday
Gainers
Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.